Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition
Quest Diagnostics is acquiring liquid biopsy company Haystack Oncology. The startup’s technology is used for identifying cancer patients who need adjuvant therapy.
Quest Diagnostics to start coronavirus testing Monday
The lab testing company made the announcement as the virus has rapidly spread across the world, and the administration's response has received widespread criticism. LabCorp also announced the availability of its test.
presented by
Why Your Patients Are Leaving and How to Stop It
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.
Quest Diagnostics acquires Blueprint Genetics
The companies said the deal, financial terms of which were not disclosed, would enable expansion of next-generation sequencing capabilities in rare diseases.